AXL and hepatocellular carcinoma: To elucidate the molecular mechanisms underlying AXL-driven immunosuppressive phenotypes in TKI-resistant HCC, TCGA-LIHC dataset was divided into AXL-low and AXL-high groups and subjected to pathway enrichment analyses.